The ESMO Preceptorship on Head and Neck Cancer 2026 is a specialized educational course scheduled for May 13–14, 2026, in Lugano, Switzerland.

This program is designed to provide medical and clinical oncologists with a deep understanding of the management of head and neck cancers, ranging from diagnosis to advanced treatment strategies. The curriculum covers the epidemiology, etiology, and molecular biology of nasopharyngeal cancer (NPC) and head and neck squamous cell carcinoma (HNSCC).

Participants will explore multidisciplinary management approaches, including the roles of surgery, radiation therapy, and systemic therapy, with a particular emphasis on the integration of immunotherapy and the management of rare tumors. The course combines plenary lectures with interactive, case-based sessions to facilitate direct engagement between participants and international experts. Successful applicants receive complimentary registration and accommodation, and the event is accredited with 11 ESMO-MORA category 1 points.

Application.